News | Enterprise Imaging | February 06, 2019

Philips Spotlights IntelliSpace Enterprise Edition at HIMSS 2019

Next-generation enterprise-wide health informatics platform now includes IntelliSpace Precision Medicine Oncology, IntelliSpace Genomics and interoperable clinical data sharing with IntelliSpace Exchange

Philips Spotlights IntelliSpace Enterprise Edition at HIMSS 2019

February 6, 2019 — Philips announced it has expanded its IntelliSpace Enterprise Edition, which combines Philips Radiology, Cardiology portfolios and PerformanceBridge, to now include the new IntelliSpace Precision Medicine Oncology, IntelliSpace Precision Medicine Genomics and IntelliSpace Exchange solutions.

Being showcased at the Healthcare Information Management Systems Society (HIMSS) 2019 annual event, Feb. 11-15 in Orlando, Fla., the enhanced integration builds on the existing suite of offerings from IntelliSpace Enterprise Edition to provide an enterprise-wide health informatics solution. With this latest expansion, health systems now have access to advanced technology solutions to help reduce costs, improve patient and staff satisfaction, and transform towards value-based care.

Precision medicine has great potential for individualized diagnoses and treatment for cancer patients. However, due to the increasing number of complex data sources needed to leverage it effectively, clinicians need tools to help them seamlessly aggregate all key data to provide a clear, intuitive view of a patient’s condition. With the latest additions to the solution, IntelliSpace Enterprise Edition is designed to enable the seamless flow of data, information enterprise management and improved care, combining radiology, cardiology and growing towards precision medicine.

CarolinaEast, an award-winning health system for patient experience and cardiac care based in New Bern, N.C., was one of the first to collaborate with Philips to implement IntelliSpace Enterprise Edition, which began with the Philips Radiology and Cardiology portfolios. Having first implemented the solution in the fall of 2018, early results show improvements in workflow, communication and operational efficiencies.

“CarolinaEast has been working with Philips for many years, and the company has always proven to be a valuable partner. With the introduction of IntelliSpace Enterprise Edition, Philips has further demonstrated its commitment to our success by providing insight into best practices and the tools to help us achieve our critical goals,” said Mike Ciancio, imaging systems administrator, CarolinaEast Health System. “Philips has helped us identify areas for improvement so we can streamline and standardize our processes to help deliver more efficient and seamlessly integrated care.”

Philips IntelliSpace Enterprise Edition brings the managed services business model to more clinical solutions, for enterprise-wide informatics across care settings. New features include:

  • IntelliSpace Precision Medicine Oncology – features workflow solutions from analysis to treatment decision to enable healthcare organizations to effectively launch, implement and scale precision medicine programs.
  • IntelliSpace Precision Medicine Genomics – seamless workflow platform brings together genomic data alongside disease histology and patient phenotype for a comprehensive biomarker-informed diagnostic and therapeutic picture.
  • IntelliSpace Exchange – provides hospital networks the possibility to easily and seamlessly exchange clinical information, to help improve the overall experience and efficiency through standards-based interoperability.

The IntelliSpace Enterprise Edition informatics suite leverages adaptive intelligence and advanced technology, powered by Philips HealthSuite, to enable health systems to make informed and timely decisions, in the right place at the right time. Beginning in 2019, IntelliSpace Enterprise Edition will continue to expand with additional solutions across new clinical domains, and will become available to more markets internationally.

For more information: www.usa.philips.com/healthcare

Related Content

myExam Companion user interface on both systems helps technologists of every experience level achieve consistently high image quality
News | Digital Radiography (DR) | January 25, 2021
January 25, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
OptumInsight and Change Healthcare combine to advance a more modern, information and technology-enabled healthcare platform

Getty Images

News | Information Technology | January 06, 2021
January 6, 2020 — Optum, a diversified health services company and